Gabather: Awaiting progress after a quiet summer
Since the start of the TOTEMS trial in May, there have been no significant news from Gabather, and the recent Q2 report held no large surprises either. The first patient has not yet been included in the trial, although healthy volunteers have been dosed in accordance with protocol. In a recent vide…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.